Lv, Y., Chen, K., Yang, C., Zhou, D., Wei, J., Xie, W., Wu, G., Zhang, J., Pan, Q., Jin, J., Tong, Y., Yu, W. (2025). Real-world efficacy, safety, and predictive factors for response to glofitamab in Chinese patients with relapsed/refractory aggressive B-cell lymphoma: A multicenter study. Blood. https://doi.org/10.1182/blood-2025-7253